Copyright MatchingDonors.com©️ 2025 All rights reserved.
CureusCardiorenal Safety Markers With Injectable Glucagon-Like Peptide-1 (GLP-1) Agonists in Type 2 Diabetes: A Network …
PLEASANTON, Calif., Nov. 4, 2025 /PRNewswire/ — Aqua Medical, a company advancing Endoscopic Metabolic Restoration …
November 05, 2025 4 min read Add topic to email alerts …
When Crystal Gonzalez was diagnosed with diabetes in 2023, she felt lost. Balancing parenthood with …
For decades, Type-2 diabetes was seen as a slow, inevitable progression, a lifelong condition that …
Key Takeaways Insulin costs have declined over the past two years, and additional price cuts …
SYRACUSE, N.Y. — November is National Diabetes Awareness Month, highlighting a condition that affects 830 …
A large cohort study found three popular GLP-1-based diabetes drugs — semaglutide, dulaglutide, and tirzepatide …
Specialty Please choose I’m not a medical professional. Allergy and Immunology Anatomy Anesthesiology Biostatistics Cardiac/Thoracic/Vascular …
Research Highlights: Optimal cardiovascular health, based on the American Heart Association’s Life’s Essential 8 …
The prevalence of diabetes in the United States (US) continues to increase. In 2021, approximately …
Innovent Biologics, Inc.’s investigative GLP-1/glucagon (GCG) dual receptor agonist mazdutide has met its primary endpoint …